Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Teleflex Inc (NY: TFX )

221.17 -0.62 (-0.28%)
Streaming Delayed Price Updated: 2:50 PM EDT, Jul 22, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Teleflex Inc

< Previous 1 2 3 4 Next >
A Glimpse Into The Expert Outlook On Teleflex Through 4 Analysts
Via Benzinga
(TFX) - Analyzing Teleflex's Short Interest
Via Benzinga
This Medical Devices Stock Has Several Catalysts, Says Bullish Analyst
Teleflex gets an upgraded rating. Analyst Matt O'Brien takes it from Neutral to Overweight, and raises the price target from $205 to $245. 
Via Benzinga
Peering Into Teleflex's Recent Short Interest
Via Benzinga
Expert Ratings For Teleflex
Via Benzinga
How Is The Market Feeling About Teleflex?
Via Benzinga
TFX Stock Earnings: Teleflex Beats EPS, Beats Revenue for Q1 2024
TFX stock results show that Teleflex beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024. 
Via InvestorPlace
(TFX) - Analyzing Teleflex's Short Interest
Via Benzinga
Teleflex: Dividend Insights
Via Benzinga
Breaking Down Teleflex: 4 Analysts Share Their Views
Via Benzinga
Earnings Scheduled For February 22, 2024
Companies Reporting Before The Bell • Indivior (NASDAQ:INDV) is likely to report quarterly earnings at $0.28 per share on revenue of $260.00 million. 
Via Benzinga
Preview: Teleflex's Earnings
Via Benzinga
Forecasting The Future: 10 Analyst Projections For Teleflex
Via Benzinga
3 Top Stock Picks from America’s Leading SMID-Cap Fund
One of the best actively managed mutual funds to buy for SMID-Cap top stock picks is from Eaton Vance. Here are three of the top stocks. 
Via InvestorPlace
Arterial Device-Focused Inari Medical Likely Acquisition Target, Shares Are Attractively Valued: Analyst
Inari Medical with strong position in venous thrombectomy. Buy-rated by Needham with a $72 target. Undervalued shares with an 88% gross margin and anticipated double-digit revenue growth. 
Via Benzinga
EnerSys To Rally Around 20%? Here Are 10 Top Analyst Forecasts For Wednesday
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. 
Via Benzinga
The Analyst Verdict: Teleflex In The Eyes Of 7 Experts
Via Benzinga
Analyst Expectations for Teleflex's Future
Via Benzinga
Teleflex's Ex-Dividend Date Is Tuesday, Here's What You Need To Know
Via Benzinga
Analyst Ratings for Teleflex
Via Benzinga
Earnings Preview: Teleflex
Via Benzinga
Starbucks, Teleflex, Roku, Shopify And Other Big Stocks Moving Higher On Thursday
U.S. stocks traded higher, with the Dow Jones gaining more than 350 points on Thursday. Here are some big stocks recording gains in today’s session. 
Via Benzinga
Topics Stocks
Exposures US Equities
Expert Ratings for Teleflex
Via Benzinga
Earnings Scheduled For August 3, 2023
Companies Reporting Before The Bell • Cedar Fair (NYSE:FUN) is likely to report quarterly earnings at $1.10 per share on revenue of $512.74 million. 
Via Benzinga
Teleflex's Interventional Urology Portfolio Expansion Earns Overweight Rating From Bullish Analyst
Stephens analyst George Sellers reiterated an Overweight rating on Teleflex Incorporated (NYSE: TFX),  
Via Benzinga
Expert Ratings for Teleflex
Via Benzinga
Earnings Scheduled For November 2, 2023
Companies Reporting Before The Bell • AudioCodes (NASDAQ:AUDC) is estimated to report quarterly earnings at $0.18 per share on revenue of $61.52 million. 
Via Benzinga
Analyst Ratings for Teleflex
Via Benzinga
Teleflex: Dividend Insights
Via Benzinga
Teleflex Acquires Palette Life Sciences For $600M Upfront, Expands Interventional Urology Portfolio
Teleflex Incorporated (NYSE: TFX) has agreed to acquire privately-held Palette Life Sciences AB for an upfront cash payment of $600 million at closing and up to an additional $50 million upon  
Via Benzinga
< Previous 1 2 3 4 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.